![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Lunit’s Breast Cancer Detection Software Earns CE Mark
Lunit’s Breast Cancer Detection Software Earns CE Mark
Lunit has earned a CE mark for its Lunit Insight MMG, an artificial intelligence (AI)-based software program for detecting breast cancer lesions in mammography images.
The software is designed for use as a diagnostic support tool. It uses the images to produce heat maps that show the location of lesions, and it estimates the probability of malignancy.
The company said a study of the AI software showed it was more sensitive at detecting early-stage invasive cancer than radiologists.
Upcoming Events
-
21Oct